Crozet BioPharma Partners have over 200 years combined experience in the biopharmaceutical industry including project management, process development, manufacturing, analytical development, quality control, clinical research and clinical operations.
Thomas Monath, MD, FASTMH, Managing Partner and Chief Scientific Officer
Tom.Monath@crozetbiopharma.com
Dr. Monath is an internationally renowned virologist and vaccinologist with over 50 years’ experience in research on viral and bacterial diseases, 25 of which have been in the vaccines industry.
Joan Fusco, PhD, Managing Partner and Chief Development Officer
Joan.Fusco@crozetbiopharma.com
Dr. Fusco has 30 years experience in the biotechnology/vaccines industry serving across major functional areas with 20 years in executive management responsibile for technical, programmatic and general operations.
D. Gray Heppner, MD, FACP, FASTMH, Managing Partner and Chief Medical Officer
Gray.Heppner@crozetbiopharma.com
Dr. Heppner is a vaccinologist and board-certified infectious disease physician with 29 years of of research and development experience, including clinical trial design and execution in the US and overseas.
Lynda Tussey, PhD, Partner and Head of Immunology and Translational Medicine
Lynda.Tussey@crozetbiopharma.com
Dr Tussey has been a senior researcher, director and executive manager of vaccine development for over 20 years. She specializes in the transition of products from discovery to clinical stage.
Joe Crowell, Partner and Head of Technical Operations
Joe.Crowell@crozetbiopharma.com
Mr. Crowell is responsible for directing the tech transfer, process development, cGMP manufacturing and vaccine supply chain efforts in support of vaccine clinical development programs.
Tracy Kemp, MPH, Partner and Head of Clinical Operations
tracy.Kemp@crozetbiopharma.com
Tracy has 25 years of experience in global drug development and clinical operations from preclinical research through Phase I-IV trials and regulatory submissions.
Rick Nichols, MA, Partner and Head of Analytical Development and Clinical Immunology
Rick.Nichols@crozetbiopharma.com
Rick brings over 25 years of experience in vaccine research, analytical development, validation and GCLP testing of clinical trial specimens and for analytics supporting manufacturing and control of biological products.
Kelly Scappaticci, Partner and Head of Project Management
Kelly.Scappaticci@crozetbiopharma.com
Kelly has 20 years of experience in the biopharmaceutical and vaccine industry with expertise in project management and quality control.
Becky Barrentine, MBA, Partner and Head of Finance, Administration, and Communications
Becky.Barrentine@crozetbiopharma.com
Becky has 25+ years of experience in corporate business roles from marketing communications to administration to accounting & finance in a variety of industries and for non-profits to Fortune 50 firms.
Lewis Markoff, MD, Regulatory Affairs
Lew.Markoff@crozetbiopharma.com
Dr. Markoff is a widely known virologist with special expertise in vaccine development and regulatory science. He has more than 40 years experience in these fields including 27 years US FDA in the Division of Viral Products, Center for Biologics Evaluation and Research (CBER).
Michele DeVries, Regulatory Affairs
Michele.DeVries@crozetbiopharma.com
Ms. DeVries has over 20 years of experience in drug development in the biopharmaceutical industry, including work in vaccines, endocrinology, oncology, infectious disease, combination products, and dermatology.
Gary McNeil, CMC Development
Gary.McNeil@crozetbiopharma.com
Gary brings over 25 years of experience in the biotech industry. During this time he has performed bench research and developed the downstream process